Mycophenolate mofetil monotherapy: an optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients.
Land
W
W
Division of Transplant Surgery and Institute of Pathology, Medical Center of the University of Munich, Munich, Germany.
Schneeberger
H
H
Weiss
M
M
Ege
T
T
Stümpfig
L
L
D019540:Area Under Curve; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000097:blood / Q000627:therapeutic use*; D018579:Patient Selection; D010865:Pilot Projects; D011446:Prospective Studies; D012449:Safety; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D017211:Treatment Failure; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D016559:Tacrolimus